5/13
09:15 am
lbph
Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions [Yahoo! Finance]
Low
Report
Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions [Yahoo! Finance]
5/7
10:53 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Medium
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
5/7
06:35 am
lbph
Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Low
Report
Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
5/6
04:01 pm
lbph
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Medium
Report
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
5/3
11:22 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
Medium
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
5/3
09:57 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its price target raised by analysts at Wedbush from $32.00 to $34.00. They now have an "outperform" rating on the stock.
High
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its price target raised by analysts at Wedbush from $32.00 to $34.00. They now have an "outperform" rating on the stock.
5/2
04:13 pm
lbph
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Medium
Report
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
5/2
04:01 pm
lbph
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Medium
Report
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
5/1
07:15 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $36.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $36.00 price target on the stock.
4/16
10:55 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
4/10
10:19 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
4/3
09:29 am
lbph
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 [Yahoo! Finance]
Medium
Report
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 [Yahoo! Finance]
4/3
09:00 am
lbph
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Medium
Report
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
4/2
04:00 pm
lbph
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Medium
Report
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
3/27
11:32 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is a favorite amongst institutional investors who own 50% [Yahoo! Finance]
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is a favorite amongst institutional investors who own 50% [Yahoo! Finance]
3/18
03:15 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $32.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $32.00 price target on the stock.
3/18
03:12 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $60.00 price target on the stock.
3/18
02:59 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
3/16
08:04 am
lbph
Longboard Pharmaceuticals: After Stellar Gains, A Period Of Relative Calm Seems Likely [Seeking Alpha]
Medium
Report
Longboard Pharmaceuticals: After Stellar Gains, A Period Of Relative Calm Seems Likely [Seeking Alpha]
3/12
04:15 pm
lbph
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Medium
Report
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates [Yahoo! Finance]
3/12
04:01 pm
lbph
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
Medium
Report
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
3/1
04:01 pm
lbph
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Low
Report
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2/28
08:14 am
lbph
Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer's [Yahoo! Finance]
Medium
Report
Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer's [Yahoo! Finance]